Gapping up
In reaction to strong earnings/guidance: APDN +13.3%, FCEL +8.2%, ARWR +5.3%
M&A news: IRC +5.6% (agrees to be acquired by DRA Advisors funds, for $10.60 per share in cash), ICPT +4.2% (M&A speculation discussed in UK Daily Mail ), SYT +1.3% (ChemChina mulling a revised proposal to acquire Syngenta, according to Bloomberg)
Select Brazil related names showing strength: GGB +4.9%, CIG +4.7%, ENB +3.6%, SBS +3%, PBR +2.4%
Select metals/mining stocks trading higher: VALE +5.6%, AU +5.4%, MT +4.3%, RIO +1.7%, BBL +1.6%, ABX +1.4%, FCX +1.2%, AA +1.1%
Select oil/gas related names showing strength: UPL +7.9%, SDRL +2.3%, APC +1.7%, RDS.A +1.5%, TOT +1.5%, E +1.4%, BP +0.8%
Other news: KTOV +40.6% (announces that the Phase III clinical trial for KIT-302 successfully met the primary efficacy endpoint of the trial protocol as approved by the FDA), LL +26% (Whitney Tilson announced he has covered his short), UTSI +7.9% (Shanghai Phicomm Communication disclosed 31.7% active stake, stated interest in acquiring control of UTSI), WGBS +7% (Signed collaboration agreement with the Luxembourg Institute of Health), VRX +4.9% (issues response to Bloomberg article about its director Norma Provencio; also confirms new U.S. fulfillment agreements with Walgreens (WBA), along with additional participating independent pharmacies), SIRI +3.5% (attributed to new 5-year contract with Howard Stern), SNY +3.3% (Sanofi-Aventis and Boehringer Ingelheim enter asset swap negotiations; expected to be business EPS neutral in 2017 and accretive in subsequent years), NWL +3.2% (favorable commentary on Monday's Mad Money), AINV +2.8% (approves a new $50 mln stock repurchase plan ), QCOM +2.3% (believes current structure best positions itself following comprehensive review; raises Q1 EPS Guidance), MNOV +2% (Received notice of allowance for a new patent from the Chinese Patent Office which covers MN-029 (denibulin) di-hydrochloride), DIS +1.5% (may be attributed to increased buzz over Star Wars movie released this week), BA +1.4% ( raises share repurchase program to $14 bln and increased 20% to $1.09 per share), ALV +1.1% (EU New Car Reg's +13.2%), PFE +1% (increases quarterly dividend to $0.30/share from $0.28/share)
Analyst comments: TSEM +5% (initiated with an Outperform at Oppenheimer), ECA +3.2% (upgraded to Buy from Hold at Jefferies), SYMC +2.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AIG +2.4% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), FEYE +2.3% (initiated with a Buy at Evercore ISI ), COH +2.3% (upgraded to Outperform from Market Perform at Cowen ), AMGN +2.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley ), V +2% (added to Conviction Buy List at Goldman), BHP +1.5% (upgraded to Outperform from Neutral at Credit Suisse), PNRA +1.5% (upgraded to Neutral at Longbow), WPX +1.2% ( initiated with a Buy at Sun Trust Rbsn Humphrey), TXN +0.8% (upgraded to Outperform from Perform at Oppenheimer)